Serum and urinary levels of MMP-2 were higher in patients with LAM then in healthy controls and decreased after treatment with the antibiotic; however, the median of MMP-2 in serum was below the detection limit both at baseline and after treatment (50, 51). The gene discussed is MMP2; the disease is lymphangioleiomyomatosis.